Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation.

By Pieternella S in 't Anker, S. Scherjon, C. Kleijburg-van der Keur, W. Noort, F. Claas, R. Willemze, W. Fibbe, H. Kanhai. Blood, 2003

816 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts. (2008, background): “Multipotent mesenchymal stromal cells (MSC) are obtained from a variety of adult and fetal tissues, including cord blood [4], dental pulp [5], adipose tissue [6], skin [7], muscle [8], liver [9], synovium [10], pancreas [11], lung [12], amniotic fluid [13], placenta [14], peripheral blood [15], and ”
Amniotic Fluid: Not Just Fetal Urine Anymore (2005, background): “Human AF has been evaluated as a source for stem cells with initial encouraging results.(54) The potential to develop a noncontroversial source of stem cells may stimulate research in this area.”
Isolation of amniotic stem cell lines with potential for therapy (2007, background): “Cells within this heterogeneous population can give rise to diverse differentiated cells including those of adipose, muscle, bone and neuronal lineage”